Australia offers a wealth
of opportunities

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font

Investor Update: BiotechnologyClick to subscribe to this Investor Updates RSS feed

CSIRO releases strategy for future
3 Aug 2015
Australia’s national science agency, CSIRO, has released its strategy for the future – a masterplan running over the next five years to improve Australia’s record in innovation.
Bio-pharma giant links with University of Adelaide
31 Jul 2015
Fifty of AstraZeneca’s drug compounds will be given to researchers at the university for the study of new therapies.
Queensland-US initiative to develop disease-fighting drugs
2 Jul 2015
The Queensland Government is to support a Queensland-US initiative aimed at discovering and developing drugs to target diseases such as cancer, diabetes, infectious diseases and inflammatory disorders.
BIO 2015 – world’s largest biotech convention
5 Jun 2015
BIO 2015, the world’s largest biotech convention, is being held from June 15-18 in Philadelphia. Australia will be well represented, both in the larger convention and at the smaller, select Partnering Forum which is part of the overall event.
‘Open Innovation’ a catalyst for drug discovery
4 Jun 2015
Global biopharmaceutical company, AstraZeneca, has announced an ‘open innovation’ collaborative academic research program with UniQuest, the University of Queensland’s research commercialisation arm.
Australian researchers developing novel uses with 4D printing
27 Apr 2015
Australian researchers at the ARC Centre of Excellence for Electromaterials Science (ACES) are building objects in 4D, taking 3D technology to a new level.
Two Industry Growth Centre Chairs announced
26 Mar 2015
The Australian Government has appointed the Chairs of its remaining two industry growth centres, responsible for Medical Technologies and Pharmaceuticals, and Oil, Gas and Energy Resources.
CSIRO performs strongly on global benchmarks
4 Mar 2015
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, performs strongly against international benchmarks according to its annual Science Health and Excellence report 2013-14.
Janssen invests in medical research at Monash
27 Jan 2015
Global pharmaceutical company Janssen-Cilag, a subsidiary of Johnson & Johnson, has signed a three-year agreement with Australia’s Monash University to undertake collaborative research into autoimmune diseases.
Takeda partners with Australia’s Monash on gastrointestinal research
22 Dec 2014
Takeda, Japan’s largest pharmaceutical company, and Australia’s Monash University have formed a strategic research alliance to develop new medicines to address significant unmet needs in the treatment of gastrointestinal diseases and disorders.

Site Information

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.